Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death

Genes and Development

Volumn 12, Issue 18, 1998, Pages 2821-2830

  Arch, Robert H ^a,b   Gedrich, Richard W ^a,b,c   Thompson, Craig B ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMINO ACID; CD27 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CELL SURFACE RECEPTOR; CYSTEINE; GENE PRODUCT; HISTIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR; ZINC;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL SURVIVAL; GENE EXPRESSION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0032530455     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.18.2821     Document Type: Review

References (103)

1. Aizawa, S., H. Nakano, T. Ishida, R. Horie, M. Nagai, K. Ito, H. Yagita, K. Okumura, J. Inoue, and T. Watanabe. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFKB activation. J. Biol. Chem. 272: 2041-2045.
2. Akiba, H., H. Nakano, S. Nishinaka, M. Shindo, T. Kobata, M. Atsuta, C. Morimoto, C.F. Ware, N.L. Malinin, D. Wallach, H. Yagita, and K. Okumura. 1998. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-κB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κB -inducing kinase. J. Biol. Chem. 273: 13353-13358.
3. Arch, R.H. and C.B. Thompson. 1998. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol. 18: 558-565.
4. Baker, S.J. and E.P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1-9.
5. Baldwin, A.S.J. 1996. The NF-κB and IκB proteins: New discoveries and insights. Ann. Rev. Immunol. 14: 649-681.
6. Beg, A.A. and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782-784.
7. Bellon, S.F., K.K. Rodgers, D.G. Schatz, J.E. Coleman, and T.A. Steitz. 1997. Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster. Nat. Struct. Biol. 4: 586-591.
8. Bodmer J.-L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schröter, K. Becker, A. Wilson, L.E. French, J.L. Browning, H.R. MacDonald, and J. Tschopp. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6: 79-88.
9. Borden, K.L.B. and P.S. Freemont. 1996. The RING finger domain: A recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6: 395-401.
10. Borden, K.L.B., M.N. Boddy, J. Lally, N.J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P.S. Freemont. 1995. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14: 1532-1521.
11. Boucher, L.-M., L.E.M. Marengère, Y. Lu, S. Thukral, and T.W. Mak. 1997. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Comm. 233: 592-600.
12. Brink, R. and H.F. Lodish. 1998. Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB. J. Biol. Chem. 273: 4129-4134.
13. Brodeur, S.R., G. Cheng, D. Baltimore, and D.A. Thorley-Lawson. 1997. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272: 19777-19784.
14. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383: 443-446.
15. Cheng, G. and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF-and CD40L-mediated NF-κB activation. Genes & Dev. 10: 963-973.
16. Cheng, G., A.M. Cleary, Z.-S. Ye, D.I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267: 1494-1498.
17. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
18. Chinnaiyan, A.M., K. O'Rourke, G.-L. Yu, R.H. Lyons, M. Garg, D.R. Duan, L. Xing, R. Gentz, J. Ni, and V.M. Dixit. 1996. Signal transduction by DR3, a death domain containing receptor related to TNFR-1 and CD95. Science 274: 990-992.
19. Clement, M.-V. and I. Stamenkovic. 1994. Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J. Exp. Med. 180: 557-567.
20. Cleveland, J.L. and J.N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81: 479-482.
21. - T lymphocytes by 4-1BB ligand. J. Immunol. 158: 551-559.
22. Devergne, O., E. Hatzivassiliou, K.M. Izumi, K.M. Kaye, M.F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation. Mol. Cell. Biol. 16: 7098-7108.
23. DiDonato, J.A., M. Hayakawa, D.M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
24. Duckett, C.S. and C.B. Thompson. 1998. CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival. Genes & Dev. 11: 2810-2821.
25. Duckett, C.S., R.W. Gedrich, M.C. Gilfillan, and C.B. Thompson. 1997. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17: 1535-1542.
26. Force, W.R., T.C. Cheung, and C.F. Ware. 1997. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272: 30835-30840.
27. Gedrich, R.W., M.C. Gilfillan, C.S. Duckett, J.L. Van Dongen, and C.B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271: 12852-12858.
28. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180: 757-762.
29. Griffith, T.S., X. Yu, J.M. Herndon, D.R. Green, and T.A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5: 7-16.
30. Hanissian, S.H. and R.S. Geha. 1997. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6: 379-397.
31. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes & Dev. 7: 2135-2148.
32. Hsu, H., T. Xiong, and D.V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495-504.
33. Hsu, H., H.-B. Shu, M.-G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308.
34. Hu, H.M., K. O'Rourke, M.S. Boguski, and V.M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269: 30069-30072.
35. Huang, B., M. Eberstadt, E.T. Olejniczak, R.P. Meadows, and S.W. Fesik. 1996. NMR structure and mutagenesis of the Fas (Apo-1/CD95) death domain. Nature 384: 638-641.
36. Huang, S., Y. Jiang, Z. Li, E. Nishida, P. Mathias, S. Lin, R.J. Ulevitch, G.R. Nemerow, and J. Han. 1997. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity 6: 739-749.
37. Hurtado, J.C., S.H. Kim, K.E. Pollok, Z.H. Lee, and B. Kwon. 1995. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol. 155: 3360-3367.
38. Hurtado, J.C., Y.-J. Kim, and B. Kwon. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158: 2600-2609.
39. Inouye, C., N. Dhillon, and J. Thorner. 1997. Ste5 RING-H2 domain: Role in Ste4-promoted oligomerization for yeast pheromone signaling. Science 278: 103-106.
40. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J.-I. Inoue. 1996a. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. 93: 9437-9442.
41. Ishida, T., S.-i. Mizushima, S. Azuma, N. Kobayashi, S. Tojo, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J.-I. Inoue. 1996b. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271: 28745-28748.
42. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Setp, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
43. Izumi, K.M., K.M. Kaye, and E. Kieff. 1997. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. 94: 1447-1452.
44. Jang, I.K., Z.H. Lee, Y.J. Kim, S.H. Kim, and B.S. Kwon. 1998. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB. Biochem. Biophys. Res. Commun. 242: 613-620.
45. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4: 275-281.
46. Kawamata, S., T. Hori, A. Imura, A. Takaori-Kondo, and T. Uchiyama. 1998. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2-and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273: 5808-5814.
47. Kaye, K.M., O. Devergne, J.N. Harada, K.M. Izumi, R. Zalamanchili, E. Kieff, and G. Mosialos. 1996. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. 93: 11085-11090.
48. Kelliher, M.A., S. Grimm, Y. Ishida, F. Kuo, B.Z. Stanger, and P. Leder. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297-303.
49. Kuhné, M.R., M. Robbins, J.E. Hambor, M.F. Mackey, Y. Kosaka, T. Nishimura, J.P. Gigley, R.J. Noelle, and D.M. Calderhead. 1997. Assembly and regulation of the CD40 receptor complex in human B Cells. J. Exp. Med. 186: 337-342.
50. Lee, S.Y., S.Y. Lee, G. Kandala, M.-L. Liou, H.-C. Liou, and Y. Choi. 1996a. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc. Natl. Acad. Sci. 93: 9699-9703.
51. Lee, S.Y., C.G. Park, and Y. Choi. 1996b. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183: 669-674.
52. Lee, S.Y., A. Reichlin, A. Santana, K.A. Sokol, M.C. Nussenzweig, and Y. Choi. 1997a. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7: 703-713.
53. Lee, S.Y., S.Y. Lee, and Y. Choi. 1997b. TRAF-interacting Protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)-and CD30-TRAF signaling complex that inhibits TRAF2-mediated NF-κB activation. J. Exp. Med. 185: 1275-1285.
54. Liebowitz, D. 1998. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N. Eng. J. Med. 338: 1413-1421.
55. Lin, A., A. Minden, H. Martinetto, F.X. Claret, C. Lange-Carter, F. Mercurio, G.L. Johnson, and M. Karin. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268: 286-290.
56. Liu, Z.-g., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576.
57. Mackay, J.P. and M. Crossley. 1998. Zinc fingers are sticking together. Trends Biochem. Sci. 23: 1-4.
58. Malinin, N.L., M.P. Boldin, A.V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
59. Marsters, S.A., T.M. Ayres, M. Skubatch, C.L. Gray, M. Rothe, and A. Ashkenazi. 1997. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κB and AP-1. J. Biol. Chem. 273: 14029-14032.
60. Masson, R., C.H. Régnier, M.-P. Chenard, C. Wendling, M.-G. Mattei, C. Tomasetto, and M.-C. Rio. 1998. Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development. Mech. Dev. 71: 187-191.
61. McCarthy, J.V., J. Ni, and V.M. Dixit. 1998. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273: 16968-16975.
62. Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
63. Medzhitov, R.M., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Gosh, and C.A. Janeway. 1998. MyD88 is an adapter protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell (in press).
64. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723.
65. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399.
66. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827.
67. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365.
68. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C.F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271: 14661-14664.
69. Noelle, R.J. 1996. CD40 and its ligand in host defense. Immunity 4: 415-419.
70. Opipari, A.W., H.M. Hu, R. Yabkowitz, and V.M. Dixit. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267: 12424-12427.
71. Régnier, C.H., C. Tomasetto, C. Moog-Lutz, M.-P. Chenard, C. Wendling, P. Basset, and M.-C. Rio. 1995. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270: 25715-25721.
72. Régnier, C.H., H.Y. Song, X. Gao, D.V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90: 373-383.
73. Reinhard, C., B. Shamoon, V. Shyamala, and L.T. Williams. 1997. Tumor necrosis factor α-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16: 1080-1092.
74. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78: 681-692.
75. Rothe, M., M.-G. Pan, W.J. Henzel, T.M. Ayres, and D.V. Goeddel. 1995a. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252.
76. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995b. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269: 1424-1427.
77. Rothe, M., J. Xiong, H.-B. Shu, K. Williamson, A. Goddard, and D.V. Goeddel. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. 93: 8241-8246.
78. Roy, N., Q.L. Deveraux, R. Takahashi, G.S. Salvesen, and J.C. Reed. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925.
79. Saitoh, M., H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17: 2596-2606.
80. Sandberg, M., W. Hammerschmidt, and B. Sugden. 1997. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71: 4649-4656.
81. Saoulli, K., S.Y. Lee, J.L. Cannons, W.C. Yeh, A. Santana, M.D. Goldstein, N. Bangia, M.A. DeBenedette, T.W. Mak, Y. Choi, and T.H. Watts. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187: 1849-1862.
82. Sato, T., S. Irie, and J.C. Reed. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358: 113-118.
83. Shi, C.-S. and J.H. Kehrl. 1997. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2-and germinal center kinase related-dependent pathway. J. Biol. Chem. 272: 32102-32107.
84. Shuford, W.W., K. Klussman, D.D. Tritchler, D.T. Loo, J. Chalupny, A.W. Siadak, T.J. Brown, J. Emswiler, H. Raecho, C.P. Larsen, T.C. Pearson, J.A. Ledbetter, A. Aruffo, and R.S. Mittler. 1997. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186: 47-55.
85. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76: 959-962.
86. Song, H.Y., M. Rothe, and D.V. Goeddel. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. 93: 6721-6725.
87. Song, H.Y., C.H. Régnier, C.J. Kirschning, D.V. Goeddel, and M. Rothe. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. 94: 9792-9796.
88. Soong, L., J.-C. Xu, I.S. Grewal, P. Kima, J. Sun, B.J. Longley, N.H. Ruddle, D. McMahon-Pratt, and R.A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmama amazonensis infection. Immunity 4: 263-273.
89. Speiser, D.E., S.Y. Lee, B. Wong, J. Arron, A. Santana, Y.-Y. Kong, P.S. Ohashi, and Y. Choi. 1997. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185: 1777-1783.
90. Stanger, B.Z., P. Leder, T.-H. Lee, E. Kim, and B. Seed. 1995. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523.
91. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77: 727-736.
92. Takeuchi, M., M. Rothe, and D.V. Goeddel. 1996. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271: 19935-19942.
93. Tartaglia, L.A., M. Rothe, Y.-F. Hu, and D.V. Goeddel. 1993. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73: 213-216.
94. Ting, A.T., F.X. Pimentel-Muiños, and B. Seed. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189-6196.
95. Uren, A.G., M. Pakusch, C.J. Hawkins, K.L. Puls, and D.L. Vaux. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. 93: 4974-4978.
96. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
97. VanArsdale, T.L., S.L. VanArsdale, W.R. Force, B.N. Walter, G. Mosialos, E. Kieff, J.C. Reed, C.F. Ware. 1997. Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. 94: 2460-2465.
98. Van Parijs, L.A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328.
99. Verma, I.M. and J. Stevenson. 1997. IκB kinase: Beginning, not the end. Proc. Natl. Acad. Sci. 94: 11758-11760.
100. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin. 1996. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787.
101. Xu, Y., G. Cheng, and D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and detective T-dependent immune responses. Immunity 5: 407-415.
102. Yeh, W.-C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J.L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D.V. Goeddel, and T.W. Mak. 1997. Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
103. Zandi, E., D.M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.